Rising lymphocytic leukemia to augment Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Growth

 

Human Immunoglobulin (pH4) for Intravenous injection (COVID-19) Market
Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market

Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market, By Type (IgG, IgA and IgM) By Disease Indication (COVID-19, Primary Immunodeficiency Disease, Immune-mediated Thrombocytopenia, Kawasaki Disease, B Chronic lymphocytic Leukemia(B-CLL) and Others By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030

The global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market is estimated to be valued at US$ 43,205.8 million in 2020 and is expected to exhibit a CAGR of 12.7 % over the forecast period as highlighted in a new report published by Coherent Market Insights.

Market Overview

Human immunoglobulin for intravenous injection (IVIG) has the ability of proving passive resistance and anti-infection, immunomodulatory impact which results in better therapy and prediction of serious inflammation such as COVID-19. The IgG antigens extracted from recovered individuals of COVID- 19 are known to increase the immune response in recent infected patients, resulting a decrease in the time of treatment.

Covid-19 Impact Analysis:

Key players involved in the growth of global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market are ADMA Biologics, Inc., Takeda Pharmaceutical Company Limited, Hualan Biological Engineering Inc,, Baxter International Inc., CSL Behring, Bayer AG, Grifols, S.A., Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd., China Biologic Products, Inc., Boya Bio-Pharmaceutical Group Co., Ltd., Octapharma AG, Shanghai RAAS Blood Products Co., Ltd., and Sinopharm Group Co., Ltd.

Market Key Drivers:

The increasing prevalence of chronic lymphocytic leukemia, and demand for immune globulin products is expected to boost global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market. For instance, as per American Cancer Society over 60,530 new cases of leukemia were diagnosed in the U.S in 2020 out of which 21,040 new cases were chronic lymphocytic leukemia (CLL).

Rising adoption of inorganic growth strategies and collaborations is projected to propel the growth of global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market. For instance, in January 2020, ADMA Biologics, Inc., entered a 5-year production and supply agreement with a partner to generate and sell plasma-derived intermediate fractions from ADMA’s Immune Globulin production process. 

Covid-19 Impact Analysis:

The COVID-19 outbreak positively affected the growth of the global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market as it is expected to rise the demand for human immunoglobulin (pH4) for intravenous injection. These immunoglobulin antibodies are extracted from the patients who have overcome Covid-19.  All these factors propelled the market growth.

Key Takeaways:

The global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market is expected to exhibit a CAGR of 12.7 % during the forecast period owing to the rising Covid-19 cases. For instance, as per WHO, in May 3, 2023 around 765,222,932 confirmed cases of COVID-19 has been recorded.

Among regions, North America, Asia Pacific and Europe anticipated to witness robust growth in the global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market due to rising demand of IG products, rising prevalence of chronic diseases and increasing growth of key players. For instance, on August 12, 2019, the USFDA stated that necessity for immune globulin products has increased in recent years.

Comments

Post a Comment

Popular posts from this blog

Rising Cancer Cases to boost the Molecular Cytogenetics Market Growth

Image
Molecular Cytogenetics Market Molecular Cytogenetics Market by Products (Kits & Reagents, Instruments, and Software & Services), Technique (Fluorescence in Situ Hybridization, Comparative Genomic Hybridization, Karyotyping, Other Techniques), Application (Cancer, Genetic Disorders, Other Applications), And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030 The global Molecular Cytogenetics Market is estimated to be valued at US$ 4,211.4 million in 2023, and is expected to exhibit a CAGR of 24.5 % over the forecast period, as highlighted in a new report published by Coherent Market Insights. Market Overview: Clinical cytogenetics is the examination of the relation between chromosomal alterations and genetic disorders in human beings. Molecular cytogenetics is an examination of genetic diseases utilizing new techniques and methods that link cytogenetic and molecular techn
Read more

Bispecific Antibodies Are Used As Therapeutic Drugs While Treating Viral Infections, Oncology, And Auto-Immune Diseases

Image
  Bispecific Antibodies Bispecific antibodies are produced through cell fusion or recombinant DNA technologies. Bispecific antibodies are much more specific than monoclonal antibodies. Their applications in tumor immunotherapy are nearly limitless. As of today, seven bispecific antibodies have been approved by the FDA and EMA and over one hundred are in preclinical testing. Bispecific antibodies were initially developed using the quadroma technology. They contain two distinct antigen-binding arms, which enable them to bind to the target antigen while also activating an effector cell, which kills tumor cells. The primary antigen on the surface of the effector cell is called CD3, which is a popular target of immune cells. According to Coherent Market insights the Bispecific Antibodies Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028. Many of these multi specific antibody formats have been developed over the past 30 years. These categories of a
Read more

Organic Milk Has Much Higher Concentration Of Iron, Vitamin E, And Polyunsaturated Fatty Acids Omega-3 And Omega-6 As Compared To Regular Milk

Image
  Organic Milk Organic Milk is milk made from livestock raised using organic farming practices. The use of the term "organic" is regulated by food authorities in most jurisdictions. Organic cows are not allowed to be given hormones, which stimulate milk production. Organic feed also must be grown without the use of synthetic pesticides. Organic cows must get a certain percentage of their diet from grazing, although most organic dairies supplement the grass with grain. However, organic grazing cows produce less milk than cows that eat a grain-based diet. Buying organic milk may be a better investment for your health. According to Coherent Market Insights the Organic Milk Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028. The standards for organic milk are stringent. To meet the organic standard, a dairy farm cannot use any form of animal growth hormones or antibiotics. Organic cows must spend at least 30% of their lives on pasture. C
Read more